Discover how GLP-1 agonists are revolutionizing weight loss and health management as we sit down with Dr Amer Sayed, a cardiologist and an inspiring figure who has faced his own battles with obesity. Inspired by a peptide found in lizards, these medications offer a new hope for individuals struggling with weight despite leading active lifestyles. Amir's firsthand experience and professional insights reveal how these game-changing drugs can help suppress appetite, reduce gastrointestinal motility, and lead to significant improvements in blood pressure and diabetes management.

We then unravel the specifics of semaglutide and terzapatide, two prominent GLP-1 agonists, addressing critical questions about who might benefit from these medications and who should avoid them. From potential side effects like nausea and headaches to serious considerations for those with thyroid cancer or pancreatitis, we leave no stone unturned. Amir sheds light on how to manage these side effects and underscores the importance of diligent monitoring and open communication with healthcare providers to ensure patient safety.

Join us for an episode filled with invaluable insights and real-life success stories that could inspire your own path to wellness.

https://www.gatlan.com/

⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!

New episodes every other Tuesday. Subscribe so you don't miss one.

Continue this conversation on Substack: https://robertlufkinmd.substack.com
Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/

Web: https://www.robertlufkinmd.com
YouTube: https://www.youtube.com/robertlufkinmd
X: https://x.com/robertlufkinmd
Instagram: https://www.instagram.com/robertlufkinmd/
TikTok: https://www.tiktok.com/@robertlufkin
LinkedIn: https://www.linkedin.com/in/robertlufkinmd/